626
Views
73
CrossRef citations to date
0
Altmetric
Research Article

Toxicological Significance of Mechanism-Based Inactivation of Cytochrome P450 Enzymes by Drugs

&
Pages 389-412 | Published online: 10 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Jie Zhao, Jingyu He & Jie Xu. (2023) Mechanism-based inactivation of cytochrome P450 3A by evodol. Xenobiotica 53:3, pages 129-139.
Read now
Chaitanya K. Jaladanki, Anuj Gahlawat, Gajanan Rathod, Hardeep Sandhu, Kousar Jahan & Prasad V. Bharatam. (2020) Mechanistic studies on the drug metabolism and toxicity originating from cytochromes P450. Drug Metabolism Reviews 52:3, pages 366-394.
Read now
Ai-Hong Yang, Lei Zhang, De-Xian Zhi, Wen-Li Liu, Xue Gao & Xin He. (2018) Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole. Xenobiotica 48:11, pages 1164-1172.
Read now
Angelika Kaczyńska, Joanna Świerczyńska & Anna Herman-Antosiewicz. (2015) Sensitization of HER2 Positive Breast Cancer Cells to Lapatinib Using Plants-Derived Isothiocyanates. Nutrition and Cancer 67:6, pages 976-986.
Read now
Han Kiat Ho, James Chun Yip Chan, Klarissa D. Hardy & Eric Chun Yong Chan. (2015) Mechanism-based inactivation of CYP450 enzymes: a case study of lapatinib. Drug Metabolism Reviews 47:1, pages 21-28.
Read now
Derek R Duckett & Michael D Cameron. (2010) Metabolism considerations for kinase inhibitors in cancer treatment. Expert Opinion on Drug Metabolism & Toxicology 6:10, pages 1175-1193.
Read now
Bo Wen & William L Fitch. (2009) Analytical strategies for the screening and evaluation of chemically reactive drug metabolites. Expert Opinion on Drug Metabolism & Toxicology 5:1, pages 39-55.
Read now

Articles from other publishers (65)

Lloyd Wei Tat Tang & Eric Chun Yong Chan. (2022) Metabolic activation of drugs by cytochrome P450 enzymes: Biochemical insights into mechanism-based inactivation by fibroblast growth factor receptor inhibitors and chemical approaches to attenuate reactive metabolite formation. Biochemical Pharmacology 206, pages 115336.
Crossref
Kaiyi Wu, Rosaria Tizzani, Hans Zweers, Huub Rijnaarts, Alette Langenhoff & Tânia V. Fernandes. (2022) Removal processes of individual and a mixture of organic micropollutants in the presence of Scenedesmus obliquus. Science of The Total Environment 838, pages 156526.
Crossref
Min Jiang, Xiaoying Wang, Bin Lv, Yujie Lu, Xianghui Ma, Wenjuan Liu, Gang Bai & Xiumei Gao. (2022) Psoralen induces hepatotoxicity by covalently binding to glutathione-S-transferases and the hepatic cytochrome P450. Phytomedicine 104, pages 154165.
Crossref
Nancy H. C. Loos, Jos H. Beijnen & Alfred H. Schinkel. (2022) The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?. International Journal of Molecular Sciences 23:17, pages 9866.
Crossref
Lloyd Wei Tat Tang, Jiaxin Fu, Siew Kwan Koh, Guoyi Wu, Lei Zhou & Eric Chun Yong Chan. (2022) Metabolic Activation of the Acrylamide Michael Acceptor Warhead in Futibatinib to an Epoxide Intermediate Engenders Covalent Inactivation of CYP3A. Drug Metabolism and Disposition 50:7, pages 931-941.
Crossref
Xuegu Xu, Chaojie Chen, Ya-nan Liu, Xiaolei Meng, Jian-ping Cai & Ren-ai Xu. (2022) Establishment and validation of a UPLC-MS/MS bioassay for the quantification of infigratinib in rat plasma. Arabian Journal of Chemistry 15:7, pages 103893.
Crossref
Qiuying Zhang, Hui Liu, Dongmei Wu, Hongyan Yu, Kun Wang, Weijie Jiao & Xu Zhao. (2022) Methysticin Acts as a Mechanism-Based Inactivator of Cytochrome P450 2C9. Chemical Research in Toxicology.
Crossref
Lloyd Wei Tat Tang, Wan Wei, Ravi Kumar Verma, Siew Kwan Koh, Lei Zhou, Hao Fan & Eric Chun Yong Chan. (2022) Direct and Sequential Bioactivation of Pemigatinib to Reactive Iminium Ion Intermediates Culminates in Mechanism-Based Inactivation of Cytochrome P450 3A. Drug Metabolism and Disposition 50:5, pages 529-540.
Crossref
Dongzhu Tu, Jing Ning, Liwei Zou, Ping Wang, Yani Zhang, Xiangge Tian, Feng Zhang, Jiang Zheng & Guangbo Ge. (2022) Unique Oxidative Metabolism of Bufalin Generates Two Reactive Metabolites That Strongly Inactivate Human Cytochrome P450 3A. Journal of Medicinal Chemistry 65:5, pages 4018-4029.
Crossref
Jacqueline Wen Hui Leow, Lloyd Wei Tat Tang & Eric Chun Yong Chan. 2022. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary 131 176 .
Christopher A. Schofield, Tracy M. Walker, Maxine A. Taylor, Metul Patel, Denise F. Vlachou, Justyna M. Macina, Martin P. Vidgeon-Hart, Ann Williams, Paul J. McGill, Carla F. Newman & Melanie Z. Sakatis. (2021) Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury. Chemical Research in Toxicology 34:12, pages 2485-2499.
Crossref
Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, Siew Kwan Koh, Lei Zhou, Mei Lin Go, Hao Fan & Eric Chun Yong Chan. (2021) Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4. Drug Metabolism and Disposition 49:9, pages 856-868.
Crossref
Lloyd Wei Tat Tang, Jian Wei Teng, Siew Kwan Koh, Lei Zhou, Mei Lin Go & Eric Chun Yong Chan. (2021) Mechanism-Based Inactivation of Cytochrome P450 3A4 and 3A5 by the Fibroblast Growth Factor Receptor Inhibitor Erdafitinib. Chemical Research in Toxicology 34:7, pages 1800-1813.
Crossref
Jiangnan Dong, Su Li & Guangxuan Liu. (2021) Binimetinib Is a Potent Reversible and Time-Dependent Inhibitor of Cytochrome P450 1A2. Chemical Research in Toxicology 34:4, pages 1169-1174.
Crossref
Ranil C.T. Temgoua, Ugo Bussy, Dimitri Alvarez-Dorta, Nicolas Galland, Julie Hémez, Christine Thobie-Gautier, Ignas Kenfack Tonlé & Mohammed Boujtita. (2021) Using electrochemistry coupled to high resolution mass spectrometry for the simulation of the environmental degradation of the recalcitrant fungicide carbendazim. Talanta 221, pages 121448.
Crossref
Jaclyn R. Patterson, Lamont R. Terrell, Carla A. Donatelli, Dennis A. Holt, Larry J. Jolivette, Ralph A. Rivero, Theresa J. Roethke, Arthur Shu, Patrick Stoy, Guosen Ye, Mark Youngman & Brian G. Lawhorn. (2020) Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions. Journal of Medicinal Chemistry 63:23, pages 14867-14884.
Crossref
He-Shui Yu, Lin-Lin Wang, Ying He, Li-Feng Han, Hui Ding, Xin-Bo Song, Xiu-Mei Gao, Nai-Ru Yun & Zheng Li. (2020) Advances in the Study of the Potential Hepatotoxic Components and Mechanism of Polygonum multiflorum. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-12.
Crossref
Jonathan T. Seal, Stephen J. Atkinson, Helen Aylott, Paul Bamborough, Chun-wa Chung, Royston C. B. Copley, Laurie Gordon, Paola Grandi, James R. J. Gray, Lee A. Harrison, Thomas G. Hayhow, Matthew Lindon, Cassie Messenger, Anne-Marie Michon, Darren Mitchell, Alex Preston, Rab K. Prinjha, Inmaculada Rioja, Simon Taylor, Ian D. Wall, Robert J. Watson, James M. Woolven & Emmanuel H. Demont. (2020) The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor. Journal of Medicinal Chemistry 63:17, pages 9093-9126.
Crossref
Tingting Jiang, Ting Cheng, Jing Li, Mengyue Zhou, Rong Tan, Xiaojing Yang, Yang Wang, Weiwei Li & Jiang Zheng. (2020) Bergaptol, a mechanism-based inactivator of CYP2C9. Medicinal Chemistry Research 29:7, pages 1230-1237.
Crossref
Gary O. Rankin & Monica A. Valentovic. 2020. Information Resources in Toxicology. Information Resources in Toxicology 561 564 .
Run Tian, Rong Zhang, Misbah Uddin, Xianliang Qiao, Jingwen Chen & Gege Gu. (2019) Uptake and metabolism of clarithromycin and sulfadiazine in lettuce. Environmental Pollution 247, pages 1134-1142.
Crossref
Tessema Mekonnen, Ulrich Panne & Matthias Koch. (2019) Glucosylation and Glutathione Conjugation of Chlorpyrifos and Fluopyram Metabolites Using Electrochemistry/Mass Spectrometry. Molecules 24:5, pages 898.
Crossref
Yanchao Xing, Linlin Wang, Chenxi Wang, Youcai Zhang, Yi Zhang, Limin Hu, Xiumei Gao, Lifeng Han & Wenzhi Yang. (2019) Pharmacokinetic studies unveiled the drug–drug interaction between trans-2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucopyranoside and emodin that may contribute to the idiosyncratic hepatotoxicity of Polygoni Multiflori Radix. Journal of Pharmaceutical and Biomedical Analysis 164, pages 672-680.
Crossref
Leice M.R. de Novais, Cauane C.O. de Arueira, Luiz F. Ferreira, Tereza A.N. Ribeiro, Paulo T. SousaJrJr, Marcos J. Jacinto, Mário G. de Carvalho, Wagner A.S. Judice, Larissa O.P. Jesus, Aline A. de Souza, Heron F.V. Torquato, Edgar J. Paredes-Gamero & Virginia C. Silva. (2019) 4′-Hydroxy-6,7-methylenedioxy-3-methoxyflavone: A novel flavonoid from Dulacia egleri with potential inhibitory activity against cathepsins B and L. Fitoterapia 132, pages 26-29.
Crossref
Kangxin He & Qixing Zhou. (2015) Cytochrome P450 monooxygenase specific activity reduction in wheat Triticum aestivum induced by soil roxithromycin stress. Frontiers of Environmental Science & Engineering 10:2, pages 270-275.
Crossref
Elizabeth M. Sherman, Marylee V. Worley, Nathan R. Unger, Timothy P. Gauthier & Jason J. Schafer. (2015) Cobicistat: Review of a Pharmacokinetic Enhancer for HIV Infection. Clinical Therapeutics 37:9, pages 1876-1893.
Crossref
Sarah A. Sullivan, Bennett R. Streit, Ethan L. Ferguson, Paul A. Jean, Debra A. McNett, Louis T. Llames & Jennifer L. DuBois. (2015) Mass-spectrometric profiling of porphyrins in complex biological samples with fundamental, toxicological, and pharmacological applications. Analytical Biochemistry 478, pages 82-89.
Crossref
Anne-Christine Macherey & Patrick M. Dansette. 2015. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry 585 614 .
Zhi-Xin Wang, Jiazhi Sun, Caitlin E. Howell, Qing-Yu Zhou, Zhi-Xu He, Tianxin Yang, Helen Chew, Wei Duan, Zhi-Wei Zhou, Jagat R. Kanwar & Shu-Feng Zhou. (2014) Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies. Fundamental & Clinical Pharmacology 28:5, pages 551-582.
Crossref
Josie E. Parker, Andrew G. S. Warrilow, Claire L. Price, Jonathan G. L. Mullins, Diane E. Kelly & Steven L. Kelly. (2014) Resistance to antifungals that target CYP51. Journal of Chemical Biology 7:4, pages 143-161.
Crossref
Cesar Augusto Sam Tiago Vilanova-Costa, Hellen Karine Paes Porto, Flávia de Castro Pereira, Aliny Pereira de Lima, Wagner Batista dos Santos & Elisângela de Paula Silveira-Lacerda. (2014) The ruthenium complexes cis-(dichloro)tetramineruthenium(III) chloride and cis-tetraammine(oxalato)ruthenium(III) dithionate overcome resistance inducing apoptosis on human lung carcinoma cells (A549). BioMetals 27:3, pages 459-469.
Crossref
Yasuhiro Masubuchi & Yuki Kawaguchi. (2013) Time‐dependent inhibition of CYP3A4 by sertraline, a selective serotonin reuptake inhibitor. Biopharmaceutics & Drug Disposition 34:8, pages 423-430.
Crossref
Shannon Dallas, Carlo Sensenhauser, Souvik Chattopadhyay & Jose Silva. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 24 .
John C. L. Erve, Shawn Gauby, John W. MaynardJr.Jr., Mats A. Svensson, George Tonn & Kevin P. Quinn. (2013) Bioactivation of Sitaxentan in Liver Microsomes, Hepatocytes, and Expressed Human P450s with Characterization of the Glutathione Conjugate by Liquid Chromatography Tandem Mass Spectrometry. Chemical Research in Toxicology 26:6, pages 926-936.
Crossref
Wei-Sheng Lo, Yun-Ping Lim, Chien-Chih Chen, Chih-Chien Hsu, Pavel Souček, Chul-Ho Yun, Wen Xie & Yune-Fang Ueng. (2012) A dual function of the furanocoumarin chalepensin in inhibiting Cyp2a and inducing Cyp2b in mice: the protein stabilization and receptor-mediated activation. Archives of Toxicology 86:12, pages 1927-1938.
Crossref
Kevin Woodward & Kevin WoodwardK. N. Woodward. 2012. Toxicological Effects of Veterinary Medicinal Products in Humans. Toxicological Effects of Veterinary Medicinal Products in Humans 117 149 .
Melanie Z. Sakatis, Melinda J. Reese, Andrew W. Harrell, Maxine A. Taylor, Ian A. Baines, Liangfu Chen, Jackie C. Bloomer, Eric Y. Yang, Harma M. Ellens, Jeffrey L. Ambroso, Cerys A. Lovatt, Andrew D. Ayrton & Stephen E. Clarke. (2012) Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds. Chemical Research in Toxicology 25:10, pages 2067-2082.
Crossref
P. Calza, C. Medana, E. Padovano, V. Giancotti & C. Baiocchi. (2012) Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high‐resolution mass spectrometry. Rapid Communications in Mass Spectrometry 26:15, pages 1687-1704.
Crossref
Bhowmik Salil Kumar, Bong Chul Chung, Oh-Seung Kwon & Byung Hwa Jung. (2012) Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. Journal of Applied Toxicology 32:7, pages 505-520.
Crossref
Zdenek Dvorak. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics 223 258 .
Ulrich M. Zanger. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics 285 300 .
Garima Srivastava, Anubhuti Dixit, Sharawan Yadav, Devendra Kumar Patel, Om Prakash & Mahendra Pratap Singh. (2012) Resveratrol potentiates cytochrome P450 2d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radical Biology and Medicine 52:8, pages 1294-1306.
Crossref
Ho-Geon Ryu, Soo-Jin Jeong, Hee-Young Kwon, Hyo-Jung Lee, Eun-Ok Lee, Min-Ho Lee, Seung Hoon Choi, Kyoo Seok Ahn & Sung-Hoon Kim. (2012) Penta-O-galloyl-β-d-glucose attenuates cisplatin-induced nephrotoxicity via reactive oxygen species reduction in renal epithelial cells and enhances antitumor activity in Caki-2 renal cancer cells. Toxicology in Vitro 26:2, pages 206-214.
Crossref
Alexander V. LyubimovThomas A. Baillie. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions 1 24 .
Richard J. Hift, Stig Thunell & Atle Brun. (2011) Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity. Pharmacology & Therapeutics 132:2, pages 158-169.
Crossref
Mitsuhiro Wada, Rie Ikeda & Kenichiro Nakashima. 2011. Applications of Microdialysis in Pharmaceutical Science. Applications of Microdialysis in Pharmaceutical Science 465 507 .
Hideo Takakusa, Michelle D. Wahlin, Chunsheng Zhao, Kelsey L. Hanson, Lee Sun New, Eric Chun Yong Chan & Sidney D. Nelson. (2011) Metabolic Intermediate Complex Formation of Human Cytochrome P450 3A4 by Lapatinib. Drug Metabolism and Disposition 39:6, pages 1022-1030.
Crossref
Woon Chien Teng, Jing Wen Oh, Lee Sun New, Michelle D. Wahlin, Sidney D. Nelson, Han Kiat Ho & Eric Chun Yong Chan. (2010) Mechanism-Based Inactivation of Cytochrome P450 3A4 by Lapatinib. Molecular Pharmacology 78:4, pages 693-703.
Crossref
Yiding Hu, Shengtian Yang, F. Barclay Shilliday, Bruce R. Heyde, Kathy M. Mandrell, Russell H. Robins, Jin Xie, Matthew T. Reding, Yurong Lai & David C. Thompson. (2010) Novel Metabolic Bioactivation Mechanism for a Series of Anti-Inflammatory Agents (2,5-Diaminothiophene Derivatives) Mediated by Cytochrome P450 Enzymes. Drug Metabolism and Disposition 38:9, pages 1522-1531.
Crossref
Jeong Hwan Kim, Soo-Jin Jeong, Hee-Young Kwon, Sang Yoon Park, Hyo-Jung Lee, Hyo-Jeong Lee, John Charles Lieske & Sung-Hoon Kim. (2010) Decursin Prevents Cisplatin-Induced Apoptosis via the Enhancement of Antioxidant Enzymes in Human Renal Epithelial Cells. Biological and Pharmaceutical Bulletin 33:8, pages 1279-1284.
Crossref
J.M. Cullen. 2010. Comprehensive Toxicology. Comprehensive Toxicology 141 173 .
Sanjeev Kumar, Kaushik Mitra, Kelem Kassahun & Thomas A. Baillie. 2010. Adverse Drug Reactions. Adverse Drug Reactions 511 544 .
. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Gunnar Boysen, Brian F. Pachkowski, Jun Nakamura & James A. Swenberg. (2009) The formation and biological significance of N7-guanine adducts. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 678:2, pages 76-94.
Crossref
K. N. Woodward. 2009. Veterinary Pharmacovigilance. Veterinary Pharmacovigilance 423 452 .
Xiaohai Li, Yuanjun He, Claudia H. Ruiz, Marcel Koenig & Michael D. Cameron. (2009) Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways. Drug Metabolism and Disposition 37:6, pages 1242-1250.
Crossref
Juliana Feitosa-Felizzola, Khalil Hanna & Serge Chiron. (2009) Adsorption and transformation of selected human-used macrolide antibacterial agents with iron(III) and manganese(IV) oxides. Environmental Pollution 157:4, pages 1317-1322.
Crossref
W. Roth, B. Setnik, M. Zietsch, A. Burst, J. Breitenbach, E. Sellers & D. Brennan. (2009) Ethanol effects on drug release from Verapamil Meltrex®, an innovative melt extruded formulation. International Journal of Pharmaceutics 368:1-2, pages 72-75.
Crossref
Kenneth H. Grime, James Bird, Douglas Ferguson & Robert J. Riley. (2009) Mechanism-based inhibition of cytochrome P450 enzymes: An evaluation of early decision making in vitro approaches and drug–drug interaction prediction methods. European Journal of Pharmaceutical Sciences 36:2-3, pages 175-191.
Crossref
Ignazio Grattagliano, Leonilde Bonfrate, Catia V Diogo, Helen H Wang, David QH Wang & Piero Portincasa. (2009) Biochemical mechanisms in drug-induced liver injury: Certainties and doubts. World Journal of Gastroenterology 15:39, pages 4865.
Crossref
Nobuo Sekiguchi, Atsuko Higashida, Motohiro Kato, Yoshiaki Nabuchi, Tetsuya Mitsui, Kenji Takanashi, Yoshinori Aso & Masaki Ishigai. (2009) Prediction of Drug-Drug Interactions based on Time-Dependent Inhibition from High Throughput Screening of Cytochrome P450 3A4 Inhibition. Drug Metabolism and Pharmacokinetics 24:6, pages 500-510.
Crossref
Shellie M Callahan, Piyanuch Wonganan & Maria A Croyle. (2008) Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection. Virology Journal 5:1.
Crossref
J. E. Parker, M. Merkamm, N. J. Manning, D. Pompon, S. L. Kelly & D. E. Kelly. (2008) Differential Azole Antifungal Efficacies Contrasted Using a Saccharomyces cerevisiae Strain Humanized for Sterol 14α-Demethylase at the Homologous Locus . Antimicrobial Agents and Chemotherapy 52:10, pages 3597-3603.
Crossref
Anne-Christine Macherey & Patrick M. Dansette. 2008. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry 674 696 .
Jeffrey R. Huth, Danying Song, Renaldo R. Mendoza, Candice L. Black-Schaefer, Jamey C. Mack, Sarah A. Dorwin, Uri S. Ladror, Jean M. Severin, Karl A. Walter, Diane M. Bartley & Philip J. Hajduk. (2007) Toxicological Evaluation of Thiol-Reactive Compounds Identified Using a La Assay To Detect Reactive Molecules by Nuclear Magnetic Resonance. Chemical Research in Toxicology 20:12, pages 1752-1759.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.